From nose to brain: understanding transport capacity and transport rate of drugs (Q56893840)

Expert Opinion on Drug Delivery

Europe PubMed Central

title

From nose to brain: understanding transport capacity and transport rate of drugs (English)

0 references

author name string

Hongbing Wu

series ordinal

1

0 references

Kaili Hu

series ordinal

2

0 references

Xinguo Jiang

series ordinal

3

0 references

language of work or name

English

0 references

publication date

October 2008

0 references

published in

0 references

volume

5

0 references

issue

10

0 references

page(s)

1159-68

0 references

cites work

Cadmium-metallothionein interactions in the olfactory pathways of rats and pikes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Uptake of cobalt from the nasal mucosa into the brain via olfactory pathways in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Nasal delivery of antimigraine drugs: clinical rationale and evidence base

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Intranasal insulin improves memory in humans: superiority of insulin aspart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Direct access of drugs to the human brain after intranasal drug administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Delivery of interferon-beta to the monkey nervous system following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Is nose-to-brain transport of drugs in man a reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Ultrastructural characterization of the nasal respiratory epithelium in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Nose-to-brain delivery of TS-002, prostaglandin D2 analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Direct nose-to-brain transfer of morphine after nasal administration to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Permeability issues in nasal drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Synthetic biomimetic supra molecular Biovector (SMBV) particles for nasal vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Transport of drugs from the nasal cavity to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Predicting olfactory receptor neuron responses from odorant structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Endocytic and exocytic pathways of the neuronal secretory process and trans-synaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Intranasal delivery of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Drug transfer through mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Translocation of Inhaled Ultrafine Particles to the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

P-Glycoprotein attenuates brain uptake of substrates after nasal instillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Intranasal drug delivery for brain targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Analgesic effects of intra-nasal enkephalins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

UEA I-bearing nanoparticles for brain delivery following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Recent patents review on intranasal administration for CNS drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Organ targeting in vivo using phage display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Synchronous selection of homing peptides for multiple tissues by in vivo phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

In vivo phage display to identify M cell-targeting ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Phage display-derived peptides as therapeutic alternatives to antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Biodistribution of filamentous phage peptide libraries in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Transdermal protein delivery by a coadministered peptide identified via phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Filamentous phage as vector-mediated antibody delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Evidence-based pharmacotherapy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Targeted brain delivery of 17 beta-estradiol via nasally administered water soluble prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159

Biovector nanoparticles improve antinociceptive efficacy of nasal morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.10.1159